Please login to the form below

Not currently logged in
Email:
Password:

New head for Teleperformance Germany

Thomas Güther joins from Axivas

Teleperformance_Thomas-GuetherThomas Güther has joined outsource customer services provider Teleperformance as CEO of its German operations.

Güther will report directly to Norbert van Liemt, Teleperformance president of Northern Europe. He will be based at the company's German headquarters, in Dortmund.

The appointment also sees Güther take over as chief executive officer of Teleperformance-owned twenty4help and all by phone + net Dialogue Marketing and Consulting.

He joins from Axivas (formerly Alex & Gross Group), having worked at Sitel (as director of business development EMEA) and Avocis, where he was managing director and general manager for the German and Austrian business, responsible for 10 locations and 4,500 staff.

"I am convinced that we have found in Thomas Güther a manager who strengthens the trust of our German customers and our expertise will provide sustainable response in the market”, said van Liemt.

Güther's remit is to strengthen and expand Teleperformance's business in Germany.

“My task is to continue to grow profitably in the market and to gain an even better visibility, as we inspire existing and new customers. I look forward to this exciting task and to working with a dedicated team,” he said.

The Teleperformance Group is headquartered in Paris, serving more than 150 markets globally. Its German division employs some 3,300 people at seven locations.

8th July 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
W2O Group

W2O Group is an integrated marketing agency with expertise in brand and digital strategy, creative development and communications services. We...

Latest intelligence

Brain power: fresh approaches to Alzheimer’s drug discovery
New alliances are learning from past mistakes and breaking down research barriers...
Genomics integration: can the NHS rise to the challenge?
Experts gather to discuss the UK’s genomic landscape...
London
“Brexit has been a catalyst for UK clinical research... it’s turbocharged change”
The UK clinical trials environment has been transformed in recent years – but can it really buck Brexit’s risks and uncertainties?...

Infographics